Insider Transactions in Q1 2025 at Avidity Biosciences, Inc. (RNA)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 03
2025
|
Kathleen P. Gallagher Chief Program Officer |
SELL
Open market or private sale
|
Direct |
5,875
-10.41%
|
$188,000
$32.16 P/Share
|
|
Feb 03
2025
|
Kathleen P. Gallagher Chief Program Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,875
+9.43%
|
$94,000
$16.65 P/Share
|
|
Jan 22
2025
|
Kathleen P. Gallagher Chief Program Officer |
SELL
Open market or private sale
|
Direct |
5,629
-10.02%
|
$168,870
$30.16 P/Share
|
|
Jan 21
2025
|
Michael F Mac Lean Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,287
-1.53%
|
$92,036
$28.59 P/Share
|
|
Jan 21
2025
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
1,872
-12.62%
|
$52,416
$28.6 P/Share
|
|
Jan 21
2025
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
10,397
-1.51%
|
$291,116
$28.59 P/Share
|
|
Jan 21
2025
|
W. Michael Flanagan Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,672
-2.94%
|
$158,816
$28.6 P/Share
|
|
Jan 21
2025
|
Teresa Mc Carthy Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
2,959
-1.38%
|
$82,852
$28.6 P/Share
|
|
Jan 21
2025
|
Steven George Hughes Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,947
-2.31%
|
$110,516
$28.6 P/Share
|
|
Jan 21
2025
|
Kathleen P. Gallagher Chief Program Officer |
SELL
Open market or private sale
|
Direct |
3,782
-2.14%
|
$105,896
$28.59 P/Share
|
|
Jan 06
2025
|
W. Michael Flanagan Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+20.38%
|
-
|
|
Jan 06
2025
|
Teresa Mc Carthy Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+18.82%
|
-
|
|
Jan 06
2025
|
Sarah Boyce President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
82,500
+19.17%
|
-
|
|
Jan 06
2025
|
Michael F Mac Lean Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+18.81%
|
-
|
|
Jan 06
2025
|
John B Moriarty Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+33.33%
|
-
|
|
Jan 06
2025
|
Steven George Hughes Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+22.45%
|
-
|
|
Jan 06
2025
|
Eric Mosbrooker Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+29.03%
|
-
|
|
Jan 06
2025
|
Kathleen P. Gallagher Chief Program Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+29.42%
|
-
|
|
Jan 06
2025
|
Charles Calderaro Iii Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+50.0%
|
-
|